Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) increases the risk of mental health disorders, but its impact on Black Asian Minority Ethnic groups isn't fully known.

Black patients are underrepresented in alopecia research, highlighting the need for more inclusive studies.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

Zinc supplements improved symptoms in a Uyghur infant with a rare genetic disorder affecting zinc absorption.

Gender-diverse people face more depression and anxiety, partly due to stress and lower cortisol levels.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

COVID-19 affected Black communities more in Oakland County, MI, but didn't increase death rates.

Hispanic and Black patients are underrepresented in alopecia areata clinical trials.

Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.

The Dermatology Life Quality Index is reliable and consistent but needs more diverse participant studies.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

High proliferative activity and peripheral invasion indicate malignancy in canine sebaceous gland tumors; the term 'epithelioma' should be updated for clarity.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Androgen measurements are mostly unnecessary for diagnosing PCOS, except in women with menstrual issues.

Migrants from certain regions had a higher risk of COVID-19 than Spaniards.

Gender-diverse individuals face more depression and anxiety, possibly due to unique stress profiles.

Certain immune cells worsen post-surgery gut paralysis by activating a specific immune response.

Alopecia areata affects 1 in 50 people, with non-White ethnic groups experiencing the most impact on mental health and work.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Direct-to-consumer teledermatology is not effectively reaching underserved populations due to language, technology, and insurance barriers.

Women with PCOS from minority backgrounds have worse mental health and quality of life.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Social rejection can harm long-term mental health in transgender individuals.

COVID-19 can cause long-lasting non-respiratory symptoms, especially in women.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.